The Borg scale is a sustainable method for prescribing and monitoring self-administered aerobic endurance exercise in patients with chronic kidney disease
(2023) In European Journal of Physiotherapy 25(5). p.265-273- Abstract
Aim: To examine adherence, performance, and safety of self-administered aerobic endurance exercise when exercise intensity was prescribed and self-monitored with the Borg RPE scale in patients with chronic kidney disease (CKD), and the relationship between performed exercise and change in walking distance. Materials and Methods: 97 men and 50 women (age 66 ± 14 years, measured GFR 22 ± 8 mL/min/1.73m2) were prescribed 60 min aerobic endurance exercise/week at RPE 13–15. The 6-minute walk test was measured at 0, 4, 8 and 12 months of exercise. Results: 100 patients completed the study, 80% reported exercise intensity at 12 months, 74% performed exercise within the prescribed RPE. Median RPE was 13 (13–15). Median duration was... (More)
Aim: To examine adherence, performance, and safety of self-administered aerobic endurance exercise when exercise intensity was prescribed and self-monitored with the Borg RPE scale in patients with chronic kidney disease (CKD), and the relationship between performed exercise and change in walking distance. Materials and Methods: 97 men and 50 women (age 66 ± 14 years, measured GFR 22 ± 8 mL/min/1.73m2) were prescribed 60 min aerobic endurance exercise/week at RPE 13–15. The 6-minute walk test was measured at 0, 4, 8 and 12 months of exercise. Results: 100 patients completed the study, 80% reported exercise intensity at 12 months, 74% performed exercise within the prescribed RPE. Median RPE was 13 (13–15). Median duration was 56 (33–109) minutes/week. Patients with a short walking distance at baseline performed significantly less minutes of exercise/week (p = 0.039). There was no correlation between weekly duration and change in walking distance. No exercise-related incidents were recorded. Walking distance improved significantly by 30 ± 56 metres (p < 0.001). Conclusions: The Borg RPE scale is useful, acceptable, simple and safe for prescribing and monitoring intensity of self-administered aerobic endurance exercise in patients with CKD. A RPE of 13–15 improved walking distance in well-functioning and deconditioned patients, within a wide range of weekly duration of exercise.
(Less)
- author
- Svensson, Philippa LU ; Hellberg, Matthias LU ; Zhou, Yunan LU ; Wisén, Anita LU and Clyne, Naomi LU
- organization
- publishing date
- 2023
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- 6-minute walk test, chronic kidney disease, exercise -cardiovascular, exercise prescription, rehabilitation, the Borg scale, Training -aerobic
- in
- European Journal of Physiotherapy
- volume
- 25
- issue
- 5
- pages
- 265 - 273
- publisher
- Informa Healthcare
- external identifiers
-
- scopus:85132379992
- ISSN
- 2167-9169
- DOI
- 10.1080/21679169.2022.2086293
- language
- English
- LU publication?
- yes
- additional info
- Publisher Copyright: © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
- id
- 7de56f3e-a764-4c6c-a5f2-87f0da3e26e5
- date added to LUP
- 2022-07-09 19:22:26
- date last changed
- 2023-12-21 09:21:28
@article{7de56f3e-a764-4c6c-a5f2-87f0da3e26e5, abstract = {{<p>Aim: To examine adherence, performance, and safety of self-administered aerobic endurance exercise when exercise intensity was prescribed and self-monitored with the Borg RPE scale in patients with chronic kidney disease (CKD), and the relationship between performed exercise and change in walking distance. Materials and Methods: 97 men and 50 women (age 66 ± 14 years, measured GFR 22 ± 8 mL/min/1.73m<sup>2</sup>) were prescribed 60 min aerobic endurance exercise/week at RPE 13–15. The 6-minute walk test was measured at 0, 4, 8 and 12 months of exercise. Results: 100 patients completed the study, 80% reported exercise intensity at 12 months, 74% performed exercise within the prescribed RPE. Median RPE was 13 (13–15). Median duration was 56 (33–109) minutes/week. Patients with a short walking distance at baseline performed significantly less minutes of exercise/week (p = 0.039). There was no correlation between weekly duration and change in walking distance. No exercise-related incidents were recorded. Walking distance improved significantly by 30 ± 56 metres (p < 0.001). Conclusions: The Borg RPE scale is useful, acceptable, simple and safe for prescribing and monitoring intensity of self-administered aerobic endurance exercise in patients with CKD. A RPE of 13–15 improved walking distance in well-functioning and deconditioned patients, within a wide range of weekly duration of exercise.</p>}}, author = {{Svensson, Philippa and Hellberg, Matthias and Zhou, Yunan and Wisén, Anita and Clyne, Naomi}}, issn = {{2167-9169}}, keywords = {{6-minute walk test; chronic kidney disease; exercise -cardiovascular; exercise prescription; rehabilitation; the Borg scale; Training -aerobic}}, language = {{eng}}, number = {{5}}, pages = {{265--273}}, publisher = {{Informa Healthcare}}, series = {{European Journal of Physiotherapy}}, title = {{The Borg scale is a sustainable method for prescribing and monitoring self-administered aerobic endurance exercise in patients with chronic kidney disease}}, url = {{http://dx.doi.org/10.1080/21679169.2022.2086293}}, doi = {{10.1080/21679169.2022.2086293}}, volume = {{25}}, year = {{2023}}, }